image
Benitec Biopharma Inc. BNTC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 10.68
2.69 %
$ 212 M
Market Cap
-1.94
P/E
BALANCE SHEET
52.2 M ASSETS
1069.58%
Growth Rates
1Year 1069.58%
3Years 34.67%
5Years 22.14%
7Years 16.98%
10Years 8.07%
4.96 M LIABILITIES
16.42%
Growth Rates
1Year 16.42%
3Years 53.61%
5Years 13.47%
7Years 27.79%
10Years 12.37%
47.2 M EQUITY
23290.10%
Growth Rates
1Year 23290.10%
3Years 33.16%
5Years 23.31%
7Years 16.19%
10Years 7.71%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Benitec Biopharma Inc.
image
Current Assets 51.7 M
Cash & Short-Term Investments 50.9 M
Receivables 0
Other Current Assets 808 K
Non-Current Assets 536 K
Long-Term Investments 0
PP&E 449 K
Other Non-Current Assets 87 K
Current Liabilities 4.92 M
Accounts Payable 1.35 M
Short-Term Debt 284 K
Other Current Liabilities 3.29 M
Non-Current Liabilities 38 K
Long-Term Debt 0
Other Non-Current Liabilities 38 K

Balance Sheet

Millions
Jun-2024 Jun-2023 Jun-2022 Jun-2021 Jun-2020 Jun-2019 Jun-2018 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013
ASSETS
Cash & Cash Equivalents 50.9 2.5 4.1 19.8 9.8 15.7 11.8 13.4 13.6 16.7 20.5 28.6
Short Term Investments 0 0 0 0 1 K 0.1 22 K 76.8 K 0 0 0 0
Receivables 0 0 3 K 25 K 59 K 2.5 0.1 3.4 0 0 0.1 0.1
Inventory 63 K 13 K 1.8 0 0.9 1 0.000001 65.1 K 0.1 2.1 2.6 2.5
Other Current Assets 0.8 1.3 0.8 0.8 0.9 0.5 0.8 0.6 0.1 0.3 0.4 2.5
Total Current Assets 51.7 3.7 4.8 20.6 10.8 18.7 15.3 17.0 14.5 19.2 23.6 31.4
PP&E 0.4 0.6 1.0 0.6 0.8 0.5 0.2 0.3 0.4 0.3 0.4 43.8 K
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 87 K 0.1 0.2 0.2 (0.1) 9.1 K 91.8 K 45.3 K 0 0 0 0
Other Assets 0 0 0 0 0 1 1 0 0 0 1 0
Total Assets 52.2 4.5 6.0 21.4 11.6 19.2 15.7 17.4 14.9 19.6 24.0 31.5
LIABILITIES
Accounts Payable 1.4 1.1 0.4 0.3 0.3 1.5 0.4 0.1 0.4 0.6 0.7 0.5
Short Term Debt 0.3 0.3 0.3 0.2 0.2 0 0 0 0 0 0 0
Other Current Liabilities 3.3 2.6 1.9 0.9 0.7 1.2 2.1 0.7 0.6 0.7 0.8 0.3
Total Current Liabilities 4.9 4.0 2.5 1.4 1.1 2.6 1.9 0.9 0.8 1.3 1.5 0.9
Long Term Debt 0 0.3 0.6 0 0.2 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0.2 0 0 0 0 0 0 0
Other Liabilities 38 K 0 0 0 0 0 35.3 K 26.9 K 13.4 K 0 0 0
Total Liabilities 5.0 4.3 3.1 1.4 1.3 2.6 1.9 0.9 0.8 1.3 1.5 0.9
EQUITY
Common Stock 1 K 0 1 K 1 K 1 K 114.9 120.5 119.6 110.3 99.4 122.0 117.9
Retained Earnings (190.3) (167.9) (148.3) (130.1) (116.6) (98.9) (107.9) (104.3) (98.1) (82.7) (101.5) (87.9)
Other Accumulative Comprehensive Income/Loss (0.9) (0.8) (1.2) (1.5) (2.0) 0.6 1.1 1.3 1.9 1.6 1.9 0.6
Total Equity 47.2 0.2 2.9 20.0 10.2 16.6 13.8 16.5 14.1 18.3 22.5 30.6
Total Liabilities and Equity 52.2 4.5 6.0 21.4 11.6 19.2 15.7 17.4 14.9 19.6 24.0 31.5
SHARES OUTSTANDING
Common Shares Outstanding 4.1 1.4 0.5 0.3 60.1 K 50.4 K 41.3 K 34.4 K 27.9 K 22.6 K 17.7 K 4.43 K